New diabetes clinical trial: Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers

Published on: May 07, 2024 at 11:00PM
Conditions: Diabetic Foot Ulcer; Ulcer Foot; Diabetic Foot
Interventions: Device: Mirragen Wound Matrix; Device: Fibracol
Sponsors: ETS Wound Care, LLC; Professional Education and Research Institute
Recruiting
https://ift.tt/EIYR8Dl